Hovanesian breaks down the process by which Yuvezzi received FDA approval and discusses the prescription and application of the new drug.
John Hovanesian, MD
Advertisement
John Hovanesian, MD, is the principal and owner of Harvard Eye Associates.
Articles by John Hovanesian, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Hypoparathyroidism Management During Pregnancy and Breastfeeding
2
Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD
3
Zasocitinib Bests Deucravacitinib on PsO Skin Clearance in Phase 3 Head-to-Head
4
Unmet Needs in the Hypoparathyroidism Treatment Landscape
5